Abstract
We investigated intravitreal triamcinolone acetonide injection for the treatment of macular edema due to central retinal vein occlusion in 20 patients. Mean central macular thickness at 3 days, 1, 3, 6, 12, 18, and 24 months postoperatively was different than baseline. Visual acuity did not change. Intravitreal triamcinolone injection significantly improves short-term anatomy, but recurrences and steroid-related complications were noted in the longer term.
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
Female
-
Glucocorticoids / administration & dosage*
-
Glucocorticoids / adverse effects
-
Glucocorticoids / therapeutic use
-
Humans
-
Injections
-
Intraocular Pressure / drug effects
-
Macular Edema / diagnosis
-
Macular Edema / drug therapy*
-
Macular Edema / physiopathology
-
Male
-
Middle Aged
-
Recurrence
-
Retinal Vein Occlusion / complications*
-
Tomography, Optical Coherence
-
Treatment Outcome
-
Triamcinolone Acetonide / administration & dosage*
-
Triamcinolone Acetonide / adverse effects
-
Triamcinolone Acetonide / therapeutic use
-
Visual Acuity / drug effects
-
Vitreous Body
Substances
-
Glucocorticoids
-
Triamcinolone Acetonide